The use of hormone replacement therapy in postmenopausal women with type 2 diabetes

被引:10
作者
Cefalu, WT [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Med, Endocrine Diabet & Metab Unit, Burlington, VT 05401 USA
来源
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE | 2001年 / 10卷 / 03期
关键词
D O I
10.1089/152460901300139998
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In healthy postmenopausal women, estrogen or hormone replacement therapy (ERT or HRT) can alleviate menopausal symptoms and prevent osteoporosis and may also protect against cardiovascular disease (CVD). In addition to improving lipid metabolism, there are reports that estrogen also improves parameters regulating carbohydrate metabolism, including insulin resistance, in healthy women. Therefore, it is likely that ERT or HRT would also benefit women with type 2 diabetes, not only in relieving menopausal symptoms but also in improving the metabolic abnormalities associated with diabetes and in preventing cardiovascular disease.
引用
收藏
页码:241 / 255
页数:15
相关论文
共 149 条
[1]   LONG-TERM EFFECTS OF TRANSDERMAL AND ORAL ESTROGENS ON SERUM-LIPIDS AND LIPOPROTEINS IN POSTMENOPAUSAL WOMEN [J].
ADAMI, S ;
ROSSINI, M ;
ZAMBERLAN, N ;
BERTOLDO, F ;
DORIZZI, R ;
LOCASCIO, V .
MATURITAS, 1993, 17 (03) :191-196
[2]   EFFECT OF EXOGENOUS ESTROGEN ON CARBOHYDRATE METABOLISM IN POSTMENOPAUSAL WOMEN [J].
AJABOR, LN ;
TSAI, CC ;
VELA, P ;
YEN, SSC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 113 (03) :383-&
[3]   Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate [J].
Alfie, J ;
Lugones, L ;
Belardo, A ;
Tutzer, M ;
Galarza, CR ;
Waisman, GD ;
Camera, MI .
MATURITAS, 1997, 27 (02) :163-169
[4]   TESTOSTERONE CONCENTRATIONS IN WOMEN AND MEN WITH NIDDM [J].
ANDERSSON, B ;
VERMEULEN, A ;
MARIN, P ;
BJORNTORP, P ;
LISSNER, L .
DIABETES CARE, 1994, 17 (05) :405-411
[5]   Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus [J].
Andersson, B ;
Mattsson, LA ;
Hahn, L ;
Marin, P ;
Lapidus, L ;
Holm, G ;
Bengtsson, BA ;
Bjorntorp, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :638-643
[6]   The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM [J].
Andersson, B ;
Mattsson, LÅ .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (03) :260-261
[7]   Hypertriglyceridemia as a cardiovascular risk factor [J].
Austin, MA ;
Hokanson, JE ;
Edwards, KL .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :7B-12B
[9]   ISCHEMIC-HEART-DISEASE RISK IN POSTMENOPAUSAL WOMEN - EFFECTS OF ESTROGEN USE ON GLUCOSE AND INSULIN LEVELS [J].
BARRETTCONNOR, E ;
LAAKSO, M .
ARTERIOSCLEROSIS, 1990, 10 (04) :531-534
[10]   WHY IS DIABETES-MELLITUS A STRONGER RISK FACTOR FOR FATAL ISCHEMIC-HEART-DISEASE IN WOMEN THAN IN MEN - THE RANCHO-BERNARDO STUDY [J].
BARRETTCONNOR, EL ;
COHN, BA ;
WINGARD, DL ;
EDELSTEIN, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (05) :627-631